Replies to post #190 on BioPharmetics, Inc. (fka BPIC)

[Wallstreetman]

I doubt that.The buyer is not in a position to carry thru the buy of the shell,so it is in a place where whatever price increase it sees is not a valid one and should be taken as a red flag.
JMO
WSM